Gene Symbol | Gene ID | Gene Info |
---|---|---|
HMX2
|
ENSG00000188816.3 | H6 family homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_124908838_124908989 | HMX2 | 1275 | 0.420760 | -0.67 | 4.8e-02 | Click! |
chr10_124901552_124901703 | HMX2 | 6011 | 0.179929 | -0.59 | 9.8e-02 | Click! |
chr10_124906065_124906530 | HMX2 | 1341 | 0.407458 | -0.52 | 1.5e-01 | Click! |
chr10_124902617_124903031 | HMX2 | 4814 | 0.190465 | -0.44 | 2.4e-01 | Click! |
chr10_124905622_124905885 | HMX2 | 1885 | 0.309398 | -0.43 | 2.5e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_22723256_22723780 | 2.83 |
RP11-301N24.3 |
|
73417 |
0.1 |
chr3_188139152_188139752 | 2.51 |
LPP-AS1 |
LPP antisense RNA 1 |
147002 |
0.04 |
chr21_40683413_40684326 | 2.28 |
BRWD1 |
bromodomain and WD repeat domain containing 1 |
1627 |
0.24 |
chr6_74432714_74432936 | 2.18 |
RP11-553A21.3 |
|
26971 |
0.17 |
chr17_60074998_60075962 | 2.04 |
ENSG00000242398 |
. |
7868 |
0.17 |
chr6_53304943_53305256 | 2.03 |
ENSG00000212065 |
. |
16231 |
0.17 |
chr6_129966569_129967050 | 2.01 |
ARHGAP18 |
Rho GTPase activating protein 18 |
64561 |
0.13 |
chr2_47075547_47075844 | 1.98 |
AC016722.3 |
|
4940 |
0.18 |
chr15_71341987_71342266 | 1.89 |
THSD4 |
thrombospondin, type I, domain containing 4 |
47165 |
0.15 |
chr1_183578044_183578492 | 1.88 |
NCF2 |
neutrophil cytosolic factor 2 |
18257 |
0.16 |
chr6_107009635_107010133 | 1.84 |
AIM1 |
absent in melanoma 1 |
20855 |
0.17 |
chr5_77800136_77800667 | 1.83 |
LHFPL2 |
lipoma HMGIC fusion partner-like 2 |
44573 |
0.19 |
chr13_45769539_45769983 | 1.80 |
KCTD4 |
potassium channel tetramerization domain containing 4 |
909 |
0.6 |
chr4_22515546_22516022 | 1.78 |
GPR125 |
G protein-coupled receptor 125 |
1836 |
0.52 |
chr9_97567295_97567893 | 1.77 |
ENSG00000252153 |
. |
4650 |
0.2 |
chr12_26275796_26276929 | 1.77 |
SSPN |
sarcospan |
1438 |
0.31 |
chr8_93978348_93978807 | 1.75 |
TRIQK |
triple QxxK/R motif containing |
204 |
0.96 |
chr3_128914264_128914631 | 1.72 |
CNBP |
CCHC-type zinc finger, nucleic acid binding protein |
11682 |
0.14 |
chr11_67979238_67979938 | 1.71 |
SUV420H1 |
suppressor of variegation 4-20 homolog 1 (Drosophila) |
633 |
0.74 |
chr13_75343971_75344251 | 1.71 |
ENSG00000206812 |
. |
339613 |
0.01 |
chr1_234755566_234755985 | 1.67 |
IRF2BP2 |
interferon regulatory factor 2 binding protein 2 |
10504 |
0.19 |
chr18_74188097_74188669 | 1.66 |
ZNF516 |
zinc finger protein 516 |
14352 |
0.17 |
chr17_74734284_74735284 | 1.60 |
MFSD11 |
major facilitator superfamily domain containing 11 |
631 |
0.43 |
chr12_26428456_26429005 | 1.60 |
RP11-283G6.5 |
|
3877 |
0.25 |
chr3_123476973_123477366 | 1.57 |
MYLK |
myosin light chain kinase |
35519 |
0.15 |
chr1_15504056_15504331 | 1.55 |
C1orf195 |
chromosome 1 open reading frame 195 |
6380 |
0.22 |
chr12_29895057_29895338 | 1.55 |
TMTC1 |
transmembrane and tetratricopeptide repeat containing 1 |
41534 |
0.21 |
chr1_39595445_39595950 | 1.55 |
ENSG00000206654 |
. |
8982 |
0.17 |
chr20_19795785_19795937 | 1.54 |
AL121761.2 |
Uncharacterized protein |
57182 |
0.12 |
chr5_34052813_34052964 | 1.54 |
C1QTNF3 |
C1q and tumor necrosis factor related protein 3 |
8951 |
0.23 |
chr2_43683261_43683590 | 1.51 |
ENSG00000252804 |
. |
47979 |
0.17 |
chr2_43986548_43986990 | 1.50 |
ENSG00000252490 |
. |
12720 |
0.19 |
chr8_38749440_38749591 | 1.49 |
PLEKHA2 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2 |
9238 |
0.18 |
chr15_36663589_36663740 | 1.48 |
C15orf41 |
chromosome 15 open reading frame 41 |
208148 |
0.03 |
chr1_109936676_109936954 | 1.47 |
SORT1 |
sortilin 1 |
836 |
0.57 |
chr5_14191108_14191422 | 1.45 |
TRIO |
trio Rho guanine nucleotide exchange factor |
7358 |
0.33 |
chr4_157860731_157860908 | 1.45 |
PDGFC |
platelet derived growth factor C |
31236 |
0.19 |
chr9_125766060_125766211 | 1.44 |
RABGAP1 |
RAB GTPase activating protein 1 |
29653 |
0.12 |
chr7_17410528_17410788 | 1.44 |
ENSG00000199473 |
. |
2292 |
0.4 |
chr19_1361317_1362052 | 1.44 |
MUM1 |
melanoma associated antigen (mutated) 1 |
5321 |
0.1 |
chr2_12959099_12960371 | 1.42 |
ENSG00000264370 |
. |
82242 |
0.11 |
chr16_53244701_53244919 | 1.39 |
CHD9 |
chromodomain helicase DNA binding protein 9 |
2447 |
0.31 |
chr7_30405432_30405583 | 1.39 |
GS1-114I9.1 |
|
58781 |
0.11 |
chr2_147739330_147739481 | 1.39 |
ENSG00000238860 |
. |
342134 |
0.01 |
chr2_9580081_9580232 | 1.39 |
CPSF3 |
cleavage and polyadenylation specific factor 3, 73kDa |
16143 |
0.16 |
chr14_39737352_39738045 | 1.38 |
CTAGE5 |
CTAGE family, member 5 |
1080 |
0.35 |
chr18_434239_434644 | 1.37 |
RP11-720L2.2 |
|
10025 |
0.23 |
chr1_170676508_170676659 | 1.36 |
PRRX1 |
paired related homeobox 1 |
43505 |
0.19 |
chr12_105749863_105750120 | 1.34 |
C12orf75 |
chromosome 12 open reading frame 75 |
25345 |
0.17 |
chr13_80510337_80510488 | 1.33 |
SPRY2 |
sprouty homolog 2 (Drosophila) |
403382 |
0.01 |
chr6_38230222_38230373 | 1.32 |
ENSG00000200706 |
. |
55247 |
0.15 |
chr2_224950724_224950875 | 1.32 |
SERPINE2 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
46763 |
0.17 |
chr2_40612222_40612511 | 1.30 |
SLC8A1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
45054 |
0.2 |
chr21_40192893_40193225 | 1.30 |
ETS2 |
v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
11499 |
0.28 |
chr7_40713134_40713414 | 1.29 |
AC005160.3 |
|
101883 |
0.08 |
chr3_156537447_156537706 | 1.28 |
LEKR1 |
leucine, glutamate and lysine rich 1 |
6513 |
0.3 |
chr7_80350905_80351077 | 1.27 |
CD36 |
CD36 molecule (thrombospondin receptor) |
48299 |
0.19 |
chr9_130591213_130591484 | 1.25 |
ENSG00000222421 |
. |
3674 |
0.1 |
chr11_61690283_61690510 | 1.25 |
RAB3IL1 |
RAB3A interacting protein (rabin3)-like 1 |
2655 |
0.18 |
chr7_80740177_80740328 | 1.25 |
AC005008.2 |
Uncharacterized protein |
64572 |
0.15 |
chr12_26303323_26303715 | 1.24 |
SSPN |
sarcospan |
15619 |
0.18 |
chr5_163321011_163321256 | 1.24 |
ENSG00000251998 |
. |
97962 |
0.09 |
chr4_170532685_170533303 | 1.24 |
NEK1 |
NIMA-related kinase 1 |
740 |
0.46 |
chr18_12598337_12598791 | 1.24 |
SPIRE1 |
spire-type actin nucleation factor 1 |
54520 |
0.09 |
chr9_74362936_74363179 | 1.24 |
TMEM2 |
transmembrane protein 2 |
20245 |
0.27 |
chr19_4506384_4506690 | 1.24 |
HDGFRP2 |
Hepatoma-derived growth factor-related protein 2 |
6911 |
0.09 |
chr1_186152875_186153258 | 1.23 |
GS1-174L6.4 |
|
6632 |
0.23 |
chr20_20374331_20374710 | 1.23 |
INSM1 |
insulinoma-associated 1 |
25755 |
0.22 |
chr4_171593437_171593770 | 1.23 |
ENSG00000251961 |
. |
219015 |
0.02 |
chr4_184096914_184097065 | 1.23 |
ENSG00000252048 |
. |
1095 |
0.48 |
chr5_153826475_153827364 | 1.23 |
SAP30L |
SAP30-like |
814 |
0.51 |
chr20_52556645_52557141 | 1.22 |
AC005220.3 |
|
194 |
0.96 |
chr12_22435543_22435694 | 1.22 |
ST8SIA1 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
33638 |
0.22 |
chr5_71437056_71437207 | 1.22 |
ENSG00000264099 |
. |
28163 |
0.2 |
chr7_151362944_151363227 | 1.21 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
32834 |
0.19 |
chr1_203533572_203533723 | 1.21 |
ATP2B4 |
ATPase, Ca++ transporting, plasma membrane 4 |
62042 |
0.11 |
chr4_95470032_95470452 | 1.21 |
PDLIM5 |
PDZ and LIM domain 5 |
25366 |
0.27 |
chr4_48332474_48332625 | 1.21 |
SLAIN2 |
SLAIN motif family, member 2 |
10790 |
0.24 |
chr8_48392391_48392850 | 1.21 |
SPIDR |
scaffolding protein involved in DNA repair |
39657 |
0.18 |
chr3_93562236_93562537 | 1.21 |
ENSG00000251727 |
. |
222 |
0.96 |
chr4_123704879_123705044 | 1.20 |
FGF2 |
fibroblast growth factor 2 (basic) |
42902 |
0.13 |
chr5_158179607_158179937 | 1.20 |
CTD-2363C16.1 |
|
230242 |
0.02 |
chr10_36110915_36111066 | 1.20 |
FZD8 |
frizzled family receptor 8 |
180628 |
0.03 |
chr14_69501591_69501923 | 1.19 |
ACTN1-AS1 |
ACTN1 antisense RNA 1 |
54999 |
0.12 |
chr8_17082580_17082774 | 1.19 |
CNOT7 |
CCR4-NOT transcription complex, subunit 7 |
9692 |
0.21 |
chr3_32185972_32186147 | 1.18 |
ENSG00000238646 |
. |
28089 |
0.16 |
chr6_170713316_170713467 | 1.18 |
RP1-140C12.2 |
|
9836 |
0.24 |
chr10_114021204_114021502 | 1.18 |
TECTB |
tectorin beta |
22140 |
0.23 |
chr1_101455176_101455327 | 1.17 |
AC093157.1 |
Uncharacterized protein |
510 |
0.72 |
chr20_10286775_10287859 | 1.17 |
ENSG00000211588 |
. |
55561 |
0.13 |
chr6_140264980_140265131 | 1.16 |
ENSG00000252107 |
. |
214776 |
0.02 |
chr6_103680064_103680234 | 1.16 |
ENSG00000202283 |
. |
350861 |
0.01 |
chr22_28144785_28145032 | 1.16 |
RP11-375H17.1 |
|
32440 |
0.2 |
chr11_110019213_110019563 | 1.16 |
ZC3H12C |
zinc finger CCCH-type containing 12C |
12809 |
0.3 |
chr9_37761275_37761426 | 1.16 |
TRMT10B |
tRNA methyltransferase 10 homolog B (S. cerevisiae) |
7536 |
0.18 |
chr4_119826460_119826775 | 1.16 |
SYNPO2 |
synaptopodin 2 |
16425 |
0.26 |
chr16_79646883_79647034 | 1.16 |
MAF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
12347 |
0.28 |
chr11_9172322_9172473 | 1.15 |
DENND5A |
DENN/MADD domain containing 5A |
1557 |
0.4 |
chr5_124744953_124745179 | 1.15 |
ENSG00000222107 |
. |
58242 |
0.17 |
chr18_53901184_53901335 | 1.15 |
ENSG00000201816 |
. |
154434 |
0.04 |
chr4_169526190_169526341 | 1.14 |
PALLD |
palladin, cytoskeletal associated protein |
26501 |
0.19 |
chr9_127471212_127471497 | 1.14 |
ENSG00000207737 |
. |
15365 |
0.14 |
chr3_124959622_124959984 | 1.13 |
SLC12A8 |
solute carrier family 12, member 8 |
28194 |
0.2 |
chr6_137567831_137568175 | 1.13 |
IFNGR1 |
interferon gamma receptor 1 |
27417 |
0.23 |
chr22_39889600_39889751 | 1.13 |
MIEF1 |
mitochondrial elongation factor 1 |
6430 |
0.14 |
chr1_113067430_113067581 | 1.13 |
RP4-671G15.2 |
|
6442 |
0.19 |
chr7_46792365_46792593 | 1.12 |
AC011294.3 |
Uncharacterized protein |
55759 |
0.18 |
chr15_48718889_48719040 | 1.12 |
DUT |
deoxyuridine triphosphatase |
94361 |
0.07 |
chr15_82422353_82422648 | 1.11 |
RP11-597K23.2 |
Uncharacterized protein |
41468 |
0.14 |
chr1_52215707_52215947 | 1.11 |
OSBPL9 |
oxysterol binding protein-like 9 |
20121 |
0.14 |
chr4_85602887_85603189 | 1.11 |
ENSG00000239466 |
. |
6133 |
0.27 |
chr14_59804366_59804548 | 1.11 |
ENSG00000252869 |
. |
62284 |
0.12 |
chr13_31443663_31443814 | 1.10 |
MEDAG |
mesenteric estrogen-dependent adipogenesis |
36590 |
0.17 |
chr10_54412447_54412741 | 1.10 |
RP11-556E13.1 |
|
91729 |
0.09 |
chr1_179146592_179146743 | 1.10 |
ENSG00000212338 |
. |
18941 |
0.17 |
chr6_126135548_126136266 | 1.10 |
NCOA7 |
nuclear receptor coactivator 7 |
457 |
0.81 |
chr1_25666704_25667414 | 1.10 |
ENSG00000252515 |
. |
403 |
0.75 |
chr5_53387008_53387159 | 1.10 |
ENSG00000265421 |
. |
15670 |
0.24 |
chr1_181047003_181047287 | 1.09 |
IER5 |
immediate early response 5 |
10493 |
0.21 |
chr6_22880503_22880654 | 1.09 |
ENSG00000207394 |
. |
244737 |
0.02 |
chr7_111724278_111724664 | 1.09 |
DOCK4 |
dedicator of cytokinesis 4 |
80285 |
0.1 |
chr3_114959246_114959397 | 1.09 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
93203 |
0.1 |
chr16_66604326_66604620 | 1.09 |
CMTM1 |
CKLF-like MARVEL transmembrane domain containing 1 |
4056 |
0.11 |
chr15_85458028_85458261 | 1.09 |
ENSG00000207037 |
. |
23609 |
0.13 |
chr6_42192546_42192697 | 1.09 |
MRPS10 |
mitochondrial ribosomal protein S10 |
7018 |
0.19 |
chr8_118411718_118411869 | 1.08 |
ENSG00000252852 |
. |
86026 |
0.1 |
chr22_46943714_46943865 | 1.08 |
RP3-439F8.1 |
|
6397 |
0.2 |
chr3_149814811_149814962 | 1.08 |
RP11-167H9.4 |
|
656 |
0.73 |
chr11_9774128_9774293 | 1.08 |
SBF2-AS1 |
SBF2 antisense RNA 1 |
5629 |
0.19 |
chr4_141446173_141446497 | 1.08 |
ELMOD2 |
ELMO/CED-12 domain containing 2 |
745 |
0.66 |
chr3_127778796_127778947 | 1.08 |
SEC61A1 |
Sec61 alpha 1 subunit (S. cerevisiae) |
7269 |
0.16 |
chr8_117333837_117333988 | 1.08 |
ENSG00000264815 |
. |
34324 |
0.24 |
chr6_151530649_151530800 | 1.07 |
ENSG00000238616 |
. |
8248 |
0.17 |
chr18_42747380_42747531 | 1.07 |
RP11-846C15.2 |
|
13624 |
0.26 |
chr12_12037558_12037709 | 1.07 |
ETV6 |
ets variant 6 |
1238 |
0.62 |
chr3_58034413_58034564 | 1.07 |
FLNB |
filamin B, beta |
29568 |
0.21 |
chr5_60698537_60698930 | 1.07 |
ZSWIM6 |
zinc finger, SWIM-type containing 6 |
70633 |
0.12 |
chr6_16800808_16801152 | 1.07 |
RP1-151F17.1 |
|
38837 |
0.19 |
chr5_56467993_56468852 | 1.07 |
GPBP1 |
GC-rich promoter binding protein 1 |
1353 |
0.47 |
chr8_41575770_41575921 | 1.06 |
ANK1 |
ankyrin 1, erythrocytic |
12148 |
0.18 |
chr8_17600949_17601376 | 1.06 |
ENSG00000212280 |
. |
4465 |
0.2 |
chr3_23366610_23366849 | 1.06 |
ENSG00000206728 |
. |
51431 |
0.15 |
chr11_19911790_19911941 | 1.06 |
NAV2-AS3 |
NAV2 antisense RNA 3 |
91018 |
0.08 |
chr17_41668721_41668956 | 1.06 |
ETV4 |
ets variant 4 |
11850 |
0.16 |
chr11_35512548_35512699 | 1.06 |
PAMR1 |
peptidase domain containing associated with muscle regeneration 1 |
34528 |
0.18 |
chr9_13387407_13387558 | 1.06 |
MPDZ |
multiple PDZ domain protein |
107893 |
0.07 |
chr11_9775679_9775937 | 1.06 |
SBF2-AS1 |
SBF2 antisense RNA 1 |
4031 |
0.21 |
chr2_224683617_224683768 | 1.06 |
AP1S3 |
adaptor-related protein complex 1, sigma 3 subunit |
18509 |
0.26 |
chr10_76262453_76262795 | 1.05 |
RP11-46O21.2 |
|
26452 |
0.22 |
chr2_224797142_224797406 | 1.05 |
WDFY1 |
WD repeat and FYVE domain containing 1 |
12800 |
0.19 |
chr1_115844585_115844736 | 1.05 |
RP4-663N10.1 |
|
19005 |
0.23 |
chr2_208744437_208744768 | 1.05 |
AC083900.1 |
|
9963 |
0.22 |
chr8_97583664_97583930 | 1.04 |
SDC2 |
syndecan 2 |
8780 |
0.28 |
chr2_172619572_172619723 | 1.04 |
AC068039.4 |
|
10345 |
0.22 |
chr10_69895341_69895492 | 1.04 |
ENSG00000222371 |
. |
22420 |
0.17 |
chr3_45230194_45230345 | 1.03 |
TMEM158 |
transmembrane protein 158 (gene/pseudogene) |
37501 |
0.15 |
chr6_1821253_1821404 | 1.03 |
FOXC1 |
forkhead box C1 |
210647 |
0.02 |
chr11_17867327_17867615 | 1.03 |
KCNC1 |
potassium voltage-gated channel, Shaw-related subfamily, member 1 |
109951 |
0.06 |
chr11_100748119_100748270 | 1.03 |
ARHGAP42 |
Rho GTPase activating protein 42 |
36037 |
0.15 |
chr6_160016990_160017141 | 1.03 |
SOD2 |
superoxide dismutase 2, mitochondrial |
97195 |
0.07 |
chr7_107331221_107331712 | 1.03 |
SLC26A4 |
solute carrier family 26 (anion exchanger), member 4 |
869 |
0.57 |
chr1_94018188_94018555 | 1.03 |
FNBP1L |
formin binding protein 1-like |
23104 |
0.17 |
chr4_139875717_139875868 | 1.03 |
RP11-371F15.3 |
|
16657 |
0.2 |
chr13_31294257_31294613 | 1.02 |
ALOX5AP |
arachidonate 5-lipoxygenase-activating protein |
15210 |
0.26 |
chr7_102532238_102532538 | 1.02 |
LRRC17 |
leucine rich repeat containing 17 |
21050 |
0.16 |
chr6_52373200_52373495 | 1.02 |
TRAM2 |
translocation associated membrane protein 2 |
68366 |
0.11 |
chr3_188995375_188995558 | 1.02 |
TPRG1-AS2 |
TPRG1 antisense RNA 2 |
37083 |
0.21 |
chr14_69535729_69536049 | 1.02 |
ENSG00000206768 |
. |
74781 |
0.09 |
chr6_139729934_139730085 | 1.02 |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
34252 |
0.22 |
chr18_60449347_60449701 | 1.02 |
AC015989.1 |
Uncharacterized protein |
41899 |
0.14 |
chr8_71471870_71472021 | 1.02 |
AC120194.1 |
|
13736 |
0.17 |
chr11_101986710_101986861 | 1.02 |
YAP1 |
Yes-associated protein 1 |
3540 |
0.21 |
chr5_141998017_141998291 | 1.02 |
FGF1 |
fibroblast growth factor 1 (acidic) |
2753 |
0.29 |
chr3_17674402_17674598 | 1.02 |
TBC1D5 |
TBC1 domain family, member 5 |
9092 |
0.27 |
chr11_101733462_101733613 | 1.01 |
ANGPTL5 |
angiopoietin-like 5 |
45128 |
0.16 |
chr12_27768637_27769056 | 1.01 |
PPFIBP1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
16565 |
0.2 |
chr20_43169764_43169915 | 1.01 |
PKIG |
protein kinase (cAMP-dependent, catalytic) inhibitor gamma |
9269 |
0.15 |
chr16_54480360_54480511 | 1.01 |
ENSG00000264079 |
. |
102873 |
0.08 |
chr3_120155257_120155408 | 1.01 |
FSTL1 |
follistatin-like 1 |
14506 |
0.24 |
chr7_115872460_115873536 | 1.00 |
AC073130.3 |
|
6307 |
0.23 |
chr5_97644195_97644346 | 1.00 |
ENSG00000223053 |
. |
330665 |
0.01 |
chr3_160113132_160113306 | 1.00 |
IFT80 |
intraflagellar transport 80 homolog (Chlamydomonas) |
3776 |
0.16 |
chr2_46547386_46547537 | 1.00 |
EPAS1 |
endothelial PAS domain protein 1 |
22920 |
0.23 |
chr1_182998943_182999094 | 1.00 |
LAMC1 |
laminin, gamma 1 (formerly LAMB2) |
6423 |
0.22 |
chr4_177700103_177700254 | 1.00 |
VEGFC |
vascular endothelial growth factor C |
13703 |
0.29 |
chr12_66322607_66323042 | 1.00 |
AC090673.2 |
Uncharacterized protein |
4857 |
0.21 |
chr17_20840161_20840312 | 1.00 |
RP11-344E13.3 |
|
1597 |
0.25 |
chr2_189849137_189849288 | 1.00 |
ENSG00000221502 |
. |
6394 |
0.23 |
chr2_15309647_15309798 | 1.00 |
NBAS |
neuroblastoma amplified sequence |
20799 |
0.29 |
chr11_65670977_65671147 | 0.99 |
FOSL1 |
FOS-like antigen 1 |
3018 |
0.11 |
chr6_45042698_45042910 | 0.99 |
SUPT3H |
suppressor of Ty 3 homolog (S. cerevisiae) |
119557 |
0.06 |
chr10_91954011_91954162 | 0.99 |
ENSG00000222451 |
. |
30369 |
0.26 |
chr17_11992757_11992908 | 0.99 |
ENSG00000266297 |
. |
7616 |
0.24 |
chr4_166793804_166794189 | 0.99 |
TLL1 |
tolloid-like 1 |
414 |
0.92 |
chr3_142695571_142696006 | 0.99 |
RP11-372E1.6 |
|
12449 |
0.15 |
chr3_128267799_128268165 | 0.99 |
C3orf27 |
chromosome 3 open reading frame 27 |
26947 |
0.16 |
chr3_110133205_110133356 | 0.99 |
ENSG00000221206 |
. |
137532 |
0.05 |
chr12_118798649_118798918 | 0.99 |
TAOK3 |
TAO kinase 3 |
1258 |
0.54 |
chr2_237652695_237652846 | 0.99 |
ACKR3 |
atypical chemokine receptor 3 |
174486 |
0.03 |
chr9_33107993_33108144 | 0.99 |
B4GALT1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
20129 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.5 | 1.4 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.5 | 1.8 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.4 | 3.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.4 | 2.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 1.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.4 | 1.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.3 | 1.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.3 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.0 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.3 | 1.9 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.3 | 0.9 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.3 | 0.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.3 | 0.9 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 1.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.3 | 1.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 0.6 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.3 | 1.6 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.3 | 0.5 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 0.8 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.3 | 0.8 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 0.3 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.2 | 0.5 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.2 | 0.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 0.7 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.2 | 0.5 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 0.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.7 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.2 | 0.4 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.2 | 0.6 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.2 | 1.5 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.2 | 0.2 | GO:0035412 | catenin import into nucleus(GO:0035411) regulation of catenin import into nucleus(GO:0035412) |
0.2 | 0.8 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 0.8 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.2 | 1.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 1.0 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 0.6 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.9 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 1.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.2 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.5 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 1.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.3 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 0.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.5 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.2 | 0.5 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.2 | 0.5 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.2 | 1.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.6 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.4 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.7 | GO:0060840 | artery development(GO:0060840) |
0.1 | 0.6 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.6 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 1.0 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.4 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.3 | GO:0051284 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.1 | 0.8 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 1.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.5 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.4 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 1.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.4 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.1 | 0.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.5 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.1 | 0.3 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 0.1 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.1 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.4 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.4 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.1 | 0.5 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 0.5 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.4 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.4 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 1.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.4 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.3 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.1 | GO:0060197 | cloaca development(GO:0035844) skin morphogenesis(GO:0043589) cloacal septation(GO:0060197) |
0.1 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 0.2 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 2.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.7 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.4 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.1 | GO:0050955 | sensory perception of temperature stimulus(GO:0050951) thermoception(GO:0050955) |
0.1 | 0.9 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 1.2 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.1 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.3 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.1 | 1.2 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.1 | 0.3 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.6 | GO:0010092 | organ induction(GO:0001759) specification of organ identity(GO:0010092) |
0.1 | 0.2 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.1 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.1 | 1.1 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.5 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.2 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.1 | 0.4 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.7 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.1 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.4 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 2.7 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.1 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.3 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.9 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.2 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.5 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.3 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 0.2 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.1 | 0.8 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.5 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.2 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.1 | 0.3 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.1 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.2 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.1 | GO:0060872 | semicircular canal development(GO:0060872) |
0.1 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.1 | GO:0051323 | mitotic metaphase(GO:0000089) metaphase(GO:0051323) |
0.1 | 0.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.2 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 1.5 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 1.0 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.2 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.1 | 0.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.2 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.1 | 0.9 | GO:0006693 | prostaglandin metabolic process(GO:0006693) |
0.1 | 0.3 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.2 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.1 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.1 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.3 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.1 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.2 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.8 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.1 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 1.3 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.1 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.2 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.1 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.1 | 0.5 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.1 | 0.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.1 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.2 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.1 | 0.2 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.1 | 0.6 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.6 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 0.1 | GO:0060413 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.1 | 0.1 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.3 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.1 | 0.1 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.1 | 0.2 | GO:0097035 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) regulation of membrane lipid distribution(GO:0097035) |
0.1 | 0.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.2 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.1 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.1 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.1 | 0.5 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.1 | 0.2 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.5 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.0 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.0 | 0.0 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.0 | 0.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 1.0 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.1 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.0 | 0.1 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.0 | 0.2 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.2 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.0 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.0 | 0.0 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.0 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.0 | 0.0 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 0.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.0 | 0.1 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.4 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.0 | 0.1 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.0 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.0 | 0.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.2 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.0 | 0.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 1.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.2 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.0 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.2 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.2 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.0 | 0.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.5 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0051135 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) regulation of NK T cell activation(GO:0051133) positive regulation of NK T cell activation(GO:0051135) |
0.0 | 0.3 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.0 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.3 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.2 | GO:0061515 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.4 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.3 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.0 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.0 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.0 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) deoxyribose phosphate catabolic process(GO:0046386) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.2 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.2 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.1 | GO:0016265 | obsolete death(GO:0016265) |
0.0 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0051608 | histamine secretion(GO:0001821) histamine transport(GO:0051608) |
0.0 | 0.0 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.3 | GO:0071453 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.0 | 0.0 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0090190 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.0 | 0.1 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.3 | GO:0098764 | meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.4 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.2 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.2 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.0 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.1 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.2 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
0.0 | 0.1 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.0 | 0.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.2 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.0 | GO:0010662 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.1 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.0 | 0.0 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.0 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.0 | GO:0090273 | somatostatin secretion(GO:0070253) regulation of somatostatin secretion(GO:0090273) |
0.0 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.0 | 0.0 | GO:1902224 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) ketone body metabolic process(GO:1902224) |
0.0 | 0.2 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.2 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.1 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.1 | GO:0044851 | hair cycle phase(GO:0044851) hair follicle maturation(GO:0048820) |
0.0 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.0 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.1 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.0 | GO:1904251 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 0.0 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 0.1 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.0 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 3.0 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.6 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.0 | 0.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.0 | GO:0044268 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.0 | 0.1 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 0.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.4 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.0 | 0.1 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 1.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.1 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.3 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.1 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.0 | 0.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.0 | 0.1 | GO:0009584 | detection of visible light(GO:0009584) |
0.0 | 0.0 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.0 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.0 | 0.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.2 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
0.0 | 1.8 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.3 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.1 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.1 | GO:0051956 | negative regulation of organic acid transport(GO:0032891) negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.3 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.0 | 0.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.1 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.1 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.0 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.0 | 0.4 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.1 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.0 | 0.0 | GO:0060914 | heart formation(GO:0060914) |
0.0 | 0.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.0 | GO:0070295 | renal water absorption(GO:0070295) |
0.0 | 0.0 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.0 | 0.0 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.0 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.0 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.0 | 0.1 | GO:1900076 | regulation of insulin receptor signaling pathway(GO:0046626) regulation of cellular response to insulin stimulus(GO:1900076) |
0.0 | 0.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.1 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.4 | 1.1 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 1.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 0.7 | GO:0032059 | bleb(GO:0032059) |
0.2 | 0.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 1.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.0 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.8 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 0.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.6 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 1.1 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.6 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.5 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.6 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.1 | 1.7 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.3 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.6 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.7 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 1.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 1.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 4.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.3 | GO:0030990 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.1 | 0.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.1 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.1 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 1.3 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.1 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 1.4 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.2 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 3.0 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.2 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.5 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.3 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 9.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 1.6 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.1 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 2.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.5 | GO:0070161 | anchoring junction(GO:0070161) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.5 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.5 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.3 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.0 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.6 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 2.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 1.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.6 | GO:0044449 | contractile fiber part(GO:0044449) |
0.0 | 0.0 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.1 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 1.2 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.9 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.1 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 1.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.4 | GO:0060205 | cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.0 | 0.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 6.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.7 | 2.0 | GO:0000987 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.6 | 2.6 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.5 | 1.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.3 | 1.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 1.7 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.3 | 1.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 1.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 1.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 1.2 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.3 | 1.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 1.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 1.4 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 1.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 0.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 1.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.6 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 0.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.6 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.2 | 0.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.6 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.2 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 0.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 0.5 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 0.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.5 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 1.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 0.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 0.9 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.2 | 0.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.6 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 2.2 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.1 | 0.7 | GO:0015368 | calcium, potassium:sodium antiporter activity(GO:0008273) calcium:cation antiporter activity(GO:0015368) |
0.1 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.7 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.7 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.5 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.6 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 2.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 1.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.5 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.3 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 1.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.3 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 0.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.7 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.5 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 5.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.3 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.5 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 1.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.1 | GO:0033265 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
0.1 | 1.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.6 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.2 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 1.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.5 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.2 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.1 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.2 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.1 | 0.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 1.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.4 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.2 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.6 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.4 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.1 | 0.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.2 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.2 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.1 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.0 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.3 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.1 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 1.4 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.2 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 3.5 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 2.3 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.0 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.4 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 1.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.2 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.3 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.0 | 0.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.3 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 1.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 0.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.0 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.2 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.0 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.1 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0043121 | neurotrophin binding(GO:0043121) nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 1.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.0 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.7 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.0 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.3 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 1.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 0.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.0 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 1.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 2.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 4.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 2.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 9.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.7 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 4.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 6.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | REACTOME PI 3K CASCADE | Genes involved in PI-3K cascade |
0.3 | 3.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 0.2 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.2 | 4.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 1.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 5.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 1.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.1 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 2.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 0.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.0 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 1.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 0.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.6 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 1.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 1.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.3 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.1 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.1 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |